<DOC>
	<DOCNO>NCT01712711</DOCNO>
	<brief_summary>The aim study evaluate effect helicobacter pylorus eradication liver fat content , liver function test , lipid profile , homeostasis model assessment-IR ( HOMA-IR ) index , anthropometric measurement ( body mass index waist circumference ) diabetic subject non-alcoholic fatty liver disease .</brief_summary>
	<brief_title>Helicobacter Pylori Eradication Diabetic Subjects With Non-alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>Helicobacter pylorus ( HP ) antigens find liver individual benign malignant liver disease . The role HP pathogenesis non-alcoholic fatty liver disease ( NAFLD ) controversial . This randomized double blind clinical trial perform diabetic dyspeptic patient positive antibody HP evidence fatty liver ultrasonography . After exclude cause , participant persistent elevate serum aminotransferase level presume NAFLD . Those NAFLD liver fat score great ( -0.64 ) positive urea breath test ( UBT ) enrol . They randomly assign lifestyle modification alone lifestyle modification plus HP eradication group . Quadruple therapy ( omeprazole , amoxicillin , bismuth subcitrate , clarithromycin ) HP eradication perform two week . HP eradication document UBT . Liver fat content , fast serum glucose , alanine aminotransferase , aspartate aminotransferase , alkaline phosphatase , triglyceride , cholesterol , high low-density lipoprotein , HOMA-IR , anthropometric measurement ( body mass index waist circumference ) check baseline six week post-treatment .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Diabetic dyspeptic patient positive antibody H.pylori persistent elevate aminotransferase level evidence fatty liver ultrasonography , refer gastroenterology clinic Alcohol use ( 20 gram per day men 10 gram per day woman per day ) , heart disease ( ischemic congestive ) , hepatic disease ( viral hepatitis , autoimmune hepatitis , wilson disease , hemochromatosis , liver mass lesion ) , renal disease ( serum creatinine concentration &gt; 1.5 mg/dl ) , severe systemic comorbidities , neoplasm , use hepatotoxic medication past 3 month , previous history peptic ulcer , previous history H.pylori eradication , existence alarm sign ( weight loss , dysphagia , anemia , vomit , positive family history gastrointestinal cancer ) , pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Steatohepatitis ,</keyword>
	<keyword>Helicobacter pylorus ,</keyword>
	<keyword>Insulin resistance ,</keyword>
	<keyword>Alanine aminotransferase ,</keyword>
	<keyword>Aspartate aminotransferase ,</keyword>
</DOC>